Genetic Analysis of CD16+ Monocyte, CD16- Monocyte and CD4+ T Lymphocyte Cells to Identify Novel Gene Expression Signatures and Develop a Diagnostic Tool for Systemic Lupus Erythematosus
ISEF · 2024 Biomedical and Health Sciences Fourth Award
Overview
Systemic lupus erythematosus (SLE) is an incurable chronic autoimmune disease in which the immune system attacks its tissues, causing widespread inflammation and organ damage. Due to the lack of a single test for SLE diagnosis, multiple generalized methods are currently employed by doctors to detect the presence of the disease. The purpose of this study was to evaluate gene expressions in CD16+ monocyte, CD16- monocyte and CD4+ T lymphocyte cells to identify gene expression signatures unique to SLE to improve diagnostic processes and outcomes for patients with SLE, or at risk of acquiring SLE. Raw gene probe data was obtained from the Gene Expression Omnibus. Statistical significance was determined by calculating p-values for gene probe expressions between healthy patients and those with SLE, covering all 54,675 gene probes and three cell types. The gene probes with the most significant statistical difference were identified and evaluated. Excluding transcription genes, the top three gene probes identified in the study were associated with the ATP6V0C, UBA1, and TGFB1 genes. Quantile-quantile plots confirmed statistical appropriateness for genetic analysis. Further evaluation determined that the ATP6V0C, UBA1 and TGFB1 genes associated with the CD16- monocyte cell type represents a unique and novel gene expression signature for the identification of SLE in patients. Gene probe expression ranges were established for these gene probes which serve as a diagnostic tool for the presence, or genetic predisposition, of SLE. This diagnostic tool can detect SLE in a single blood sample, improving diagnostic outcomes for patients and reducing healthcare costs.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2025
The Genetics Behind Systemic Lupus Erythematosus: An in silico Analysis on the HLA-DRB1 Gene to Identify High-Risk Variants
ISEF · 2023
Advancing Autoimmune Disease Treatment With AI-Assisted Gene Expression Analysis
ISEF · 2019
The Identification and Characterization of PRDM1 Co-factors in HEK Cells
ISEF · 2020
Identifying Functional Disease Drivers in Lupus Nephritis Associated with Glomerular Remodeling
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair